A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.

Susan O'Sullivan was working full-time with the Ministry of Forests and volunteering as a singer at her local art centre when ...

After the authorization to open the residency, the UPR School of Medicine takes steps to avoid falling into the mistakes of ...

Alannah Moran, from Co Wicklow, is undergoing chemotherapy following two surgeries to remove the tumour last year. She is ...

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

Everyone has probably dealt with at least a little physical pain in their life.But fortunately, the number of peop ...

Scientists at The Hospital for Sick Children (SickKids) have discovered a way to stop tumor growth before it starts for a ...

The team’s approach could offer a transformative path for children with medulloblastoma and other aggressive types of brain ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

Almost 2% of the U.S. population received prescriptions for the weight-loss and diabetes drugs semaglutide and tirzepatide in ...

A new platform for studying neuroinflammatory diseases, utilizing advanced 3D bioprinting technology has been developed.